ADRs Close Lower; XTL Biopharmaceuticals Ltd. Declines 23%

Dow Jones10/24 04:31

Social Proxy Will Operate as Fully Owned Subsidiary of XTL >XTLB

Dow Jones08/14 21:16

XTL Completed The Acquisition Of The Social Proxy And A Private Placement Of $1.5 Million >XTLB

Dow Jones08/14 21:15

Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

Benzinga06/17 20:43

XTL Biopharmaceuticals Will Issue ADSs Representing 44.6% of Issued and Outstanding Shr Cap to Hldrs of Social Proxy >XTLB

Dow Jones06/05 21:18

XTL Biopharmaceuticals Enters Agreement To Acquire AI Web Data Company The Social Proxy; Secures $1.5M In Private Placement

Benzinga06/05 21:16